These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24325576)

  • 1. Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design.
    Yao X; Bunt C; Cornish J; Quek SY; Wen J
    Chem Biol Drug Des; 2014 May; 83(5):560-75. PubMed ID: 24325576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Delivery of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Liposomes and Solid Lipid Particles: Improvement of Stability of Lactoferrin.
    Yao X; Bunt C; Cornish J; Quek SY; Wen J
    Chem Biol Drug Des; 2015 Oct; 86(4):466-75. PubMed ID: 25581616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of bovine lactoferrin in luminal extracts and mucosal homogenates from rat intestine: a prelude to oral absorption.
    Yao X; Bunt C; Cornish J; Quek SY; Wen J
    Chem Biol Drug Des; 2014 Dec; 84(6):676-84. PubMed ID: 24890384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Cellular Uptake and Transport of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Solid Lipid Nanoparticles.
    Yao X; Bunt C; Liu M; Quek SY; Shaw J; Cornish J; Wen J
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy.
    Kanwar JR; Mahidhara G; Kanwar RK
    Nanomedicine (Lond); 2012 Oct; 7(10):1521-50. PubMed ID: 22734611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation.
    Liang XF; Wang HJ; Luo H; Tian H; Zhang BB; Hao LJ; Teng JI; Chang J
    Langmuir; 2008 Jul; 24(14):7147-53. PubMed ID: 18564860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release.
    Das S; Chaudhury A; Ng KY
    Int J Pharm; 2011 Mar; 406(1-2):11-20. PubMed ID: 21168477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization.
    Sankalia MG; Mashru RC; Sankalia JM; Sutariya VB
    Eur J Pharm Biopharm; 2007 Feb; 65(2):215-32. PubMed ID: 16982178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
    Das S; Ng KY; Ho PC
    J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals.
    Liu Y; Wang Y; Zhao J
    Int J Biol Macromol; 2019 Mar; 124():667-680. PubMed ID: 30502425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Membrane Surface Modification Using Chitosan Hydrochloride and Lactoferrin on the Properties of Astaxanthin-Loaded Liposomes.
    Qiang M; Pang X; Ma D; Ma C; Liu F
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32019205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
    Liu Y; Luo X; Xu X; Gao N; Liu X
    Int J Pharm; 2017 Jan; 517(1-2):1-7. PubMed ID: 27899320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
    Agnihotri SA; Aminabhavi TM
    J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and characterization of hydrophilic drug diclofenac sodium-loaded solid lipid nanoparticles based on phospholipid complexes technology.
    Liu D; Chen L; Jiang S; Zhu S; Qian Y; Wang F; Li R; Xu Q
    J Liposome Res; 2014 Mar; 24(1):17-26. PubMed ID: 24236407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave.
    Wong TW; Nurjaya S
    Eur J Pharm Biopharm; 2008 May; 69(1):176-88. PubMed ID: 17980563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer coated liposomes for use in the oral cavity - a study of the in vitro toxicity, effect on cell permeability and interaction with mucin.
    Klemetsrud T; Kjøniksen AL; Hiorth M; Jacobsen J; Smistad G
    J Liposome Res; 2018 Mar; 28(1):62-73. PubMed ID: 27809639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis.
    Samarasinghe RM; Kanwar RK; Kanwar JR
    Biomaterials; 2014 Aug; 35(26):7522-34. PubMed ID: 24933511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
    Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
    Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
    Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
    Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.